Skip to main content
Top
Published in: BMC Nephrology 1/2005

Open Access 01-12-2005 | Research article

Barriers to successful care for chronic kidney disease

Authors: Oliver Lenz, Durga P Mekala, Daniel V Patel, Alessia Fornoni, David Metz, David Roth

Published in: BMC Nephrology | Issue 1/2005

Login to get access

Abstract

Background

The National Kidney Foundation has formulated clinical practice guidelines for patients with chronic kidney disease (K/DOQI). However, little is know about how many patients actually achieve these goals in a dedicated clinic for chronic kidney disease.

Methods

We performed a cross-sectional analysis of 198 patients with an estimated glomerular filtration rate of less than 30 ml/min/1.73 m2 and determined whether K/DOQI goals were met for calcium, phosphate, calcium-phosphate product, parathyroid hormone, albumin, bicarbonate, hemoglobin, lipids, and blood pressure.

Results

We found that only a small number of patients achieved K/DOQI targets. Recent referral to the nephrologist, failure to attend scheduled clinic appointments, African American ethnicity, diabetes, and advanced renal failure were significant predictors of low achievement of K/DOQI goals.

Conclusion

We conclude that raising awareness of chronic kidney disease and K/DOQI goals among primary care providers, early referral to a nephrologist, the exploration of socioeconomic barriers and cultural differences, and both patient and physician education are critical to improve CKD care in patients with Stage 4 and 5 CKD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130: 461-470.CrossRefPubMed Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130: 461-470.CrossRefPubMed
2.
go back to reference Foundation NK: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis. 2002, 39: S1-S000. 10.1053/ajkd.2002.32799. Foundation NK: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis. 2002, 39: S1-S000. 10.1053/ajkd.2002.32799.
3.
go back to reference Collins AJ: Anaemia management prior to dialysis: cardiovascular and cost-benefit observations. Nephrol Dial Transplant Suppl. 2003, 18: ii2-ii6.CrossRef Collins AJ: Anaemia management prior to dialysis: cardiovascular and cost-benefit observations. Nephrol Dial Transplant Suppl. 2003, 18: ii2-ii6.CrossRef
4.
go back to reference Xue JL, St Peter WL, Ebben JP, Everson SE, Collins AJ: Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. Am J Kidney Dis. 2002, 40: 1153-1161. 10.1053/ajkd.2002.36861.CrossRefPubMed Xue JL, St Peter WL, Ebben JP, Everson SE, Collins AJ: Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. Am J Kidney Dis. 2002, 40: 1153-1161. 10.1053/ajkd.2002.36861.CrossRefPubMed
5.
go back to reference Eknoyan G, Levin A, Levin NW, Foundation NK: Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis Suppl. 2003, 42: 1-201.CrossRef Eknoyan G, Levin A, Levin NW, Foundation NK: Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis Suppl. 2003, 42: 1-201.CrossRef
6.
go back to reference Stevens LA, Djurdjev O, Cardew S, Cameron EC, Levin A: Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol. 2004, 15: 770-779. 10.1097/01.ASN.0000113243.24155.2F.CrossRefPubMed Stevens LA, Djurdjev O, Cardew S, Cameron EC, Levin A: Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol. 2004, 15: 770-779. 10.1097/01.ASN.0000113243.24155.2F.CrossRefPubMed
7.
go back to reference Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J: Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int. 2004, 65: 1031-1040. 10.1111/j.1523-1755.2004.00481.x.CrossRefPubMed Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J: Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int. 2004, 65: 1031-1040. 10.1111/j.1523-1755.2004.00481.x.CrossRefPubMed
8.
go back to reference Locatelli F, Pozzoni P, Tentori F, del Vecchio L: Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant Suppl. 2003, 18: vii2-vii9.CrossRef Locatelli F, Pozzoni P, Tentori F, del Vecchio L: Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant Suppl. 2003, 18: vii2-vii9.CrossRef
9.
go back to reference Initiative KDOQ: K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis Suppl. 2004, 43: S1-S290. Initiative KDOQ: K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis Suppl. 2004, 43: S1-S290.
10.
go back to reference John R, Webb M, Young A, Stevens PE: Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis. 2004, 43: 825-835. 10.1053/j.ajkd.2003.12.046.CrossRefPubMed John R, Webb M, Young A, Stevens PE: Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis. 2004, 43: 825-835. 10.1053/j.ajkd.2003.12.046.CrossRefPubMed
11.
go back to reference Ghossein C, Serrano A, Rammohan M, Batlle D: The role of comprehensive renal clinic in chronic kidney disease stabilization and management: The Northwestern experience. Semin Nephrol. 2002, 22: 526-532.PubMed Ghossein C, Serrano A, Rammohan M, Batlle D: The role of comprehensive renal clinic in chronic kidney disease stabilization and management: The Northwestern experience. Semin Nephrol. 2002, 22: 526-532.PubMed
12.
go back to reference Yeoh HH, Rasgon S, Rutkowski M, Crooks P, Idroos M, Diesto J: Management of patients with chronic kidney disease at Kaiser Permanente. Nephrol News Issues. 2003, 17: 25-7, 30.PubMed Yeoh HH, Rasgon S, Rutkowski M, Crooks P, Idroos M, Diesto J: Management of patients with chronic kidney disease at Kaiser Permanente. Nephrol News Issues. 2003, 17: 25-7, 30.PubMed
13.
go back to reference Foundation NK: NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis. 2001, 37: S182-S238.CrossRef Foundation NK: NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis. 2001, 37: S182-S238.CrossRef
14.
go back to reference Foundation NK: K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis. 2003, 42: S1-S202. Foundation NK: K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis. 2003, 42: S1-S202.
15.
go back to reference Foundation NK: K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Am J Kidney Dis. 2004, 43: S1-S290. Foundation NK: K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Am J Kidney Dis. 2004, 43: S1-S290.
16.
17.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JLJ, Jones DW, Materson BJ, Oparil S, Wright JTJ, Roccella EJ: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003, 42: 1206-1252. 10.1161/01.HYP.0000107251.49515.c2.CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JLJ, Jones DW, Materson BJ, Oparil S, Wright JTJ, Roccella EJ: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003, 42: 1206-1252. 10.1161/01.HYP.0000107251.49515.c2.CrossRefPubMed
18.
go back to reference St Peter WL, Schoolwerth AC, McGowan T, McClellan WM: Chronic kidney disease: issues and establishing programs and clinics for improved patient outcomes. Am J Kidney Dis. 2003, 41: 903-924. 10.1016/S0272-6386(03)00188-4.CrossRefPubMed St Peter WL, Schoolwerth AC, McGowan T, McClellan WM: Chronic kidney disease: issues and establishing programs and clinics for improved patient outcomes. Am J Kidney Dis. 2003, 41: 903-924. 10.1016/S0272-6386(03)00188-4.CrossRefPubMed
19.
go back to reference Curtis BM, Ravani P, Malberti F, Kennett F, Taylor PA, Djurdjev O, Levin A: The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant. 2005, 20: 147-154. 10.1093/ndt/gfh585.CrossRefPubMed Curtis BM, Ravani P, Malberti F, Kennett F, Taylor PA, Djurdjev O, Levin A: The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant. 2005, 20: 147-154. 10.1093/ndt/gfh585.CrossRefPubMed
20.
go back to reference R.J. M, Foley RN, New JP, O'Donoghue DJ: Standard Achievement in Chronic Kidney Disease in CRISIS; Results from Chronic Renal Insufficiency Standards Implementation Study. J Am Soc Nephrol. 2004, 15: F-PO636- R.J. M, Foley RN, New JP, O'Donoghue DJ: Standard Achievement in Chronic Kidney Disease in CRISIS; Results from Chronic Renal Insufficiency Standards Implementation Study. J Am Soc Nephrol. 2004, 15: F-PO636-
21.
go back to reference USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. 2005, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, [http://www.usrds.org/atlas.htm] USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. 2005, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, [http://​www.​usrds.​org/​atlas.​htm]
22.
go back to reference Israni A, Korzelius C, Townsend R, Mesler D: Management of chronic kidney disease in an academic primary care clinic. Am J Nephrol. 2003, 23: 47-54. 10.1159/000066296.CrossRefPubMed Israni A, Korzelius C, Townsend R, Mesler D: Management of chronic kidney disease in an academic primary care clinic. Am J Nephrol. 2003, 23: 47-54. 10.1159/000066296.CrossRefPubMed
23.
go back to reference Ifudu O, Friedman EA: Managing chronic renal insufficiency--intertwined roles of non-nephrologist and nephrologist. J Natl Med Assoc. 2003, 95: 43-54.PubMedPubMedCentral Ifudu O, Friedman EA: Managing chronic renal insufficiency--intertwined roles of non-nephrologist and nephrologist. J Natl Med Assoc. 2003, 95: 43-54.PubMedPubMedCentral
24.
go back to reference Al Aly Z, Gonzalez EA, Martin KJ, Gellens ME: Achieving K/DOQI laboratory target values for bone and mineral metabolism: an uphill battle. Am J Nephrol. 2004, 24: 422-426. 10.1159/000080087.CrossRefPubMed Al Aly Z, Gonzalez EA, Martin KJ, Gellens ME: Achieving K/DOQI laboratory target values for bone and mineral metabolism: an uphill battle. Am J Nephrol. 2004, 24: 422-426. 10.1159/000080087.CrossRefPubMed
25.
go back to reference Phillips LS, Branch WT, Cook CB, Doyle JP, El Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS: Clinical inertia. Ann Intern Med. 2001, 135: 825-834.CrossRefPubMed Phillips LS, Branch WT, Cook CB, Doyle JP, El Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS: Clinical inertia. Ann Intern Med. 2001, 135: 825-834.CrossRefPubMed
26.
go back to reference Ho LT, Sprague SM: Renal osteodystrophy in chronic renal failure. Semin Nephrol. 2002, 22: 488-493. 10.1053/snep.2002.31714.CrossRefPubMed Ho LT, Sprague SM: Renal osteodystrophy in chronic renal failure. Semin Nephrol. 2002, 22: 488-493. 10.1053/snep.2002.31714.CrossRefPubMed
27.
go back to reference Coen G, Ballanti P, Bonucci E, Calabria S, Costantini S, Ferrannini M, Giustini M, Giordano R, Nicolai G, Manni M, Sardella D, Taggi F: Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH. Nephron. 2002, 91: 103-111. 10.1159/000057611.CrossRefPubMed Coen G, Ballanti P, Bonucci E, Calabria S, Costantini S, Ferrannini M, Giustini M, Giordano R, Nicolai G, Manni M, Sardella D, Taggi F: Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH. Nephron. 2002, 91: 103-111. 10.1159/000057611.CrossRefPubMed
28.
go back to reference Wang M, Hercz G, Sherrard DJ, Maloney NA, Segre GV, Pei Y: Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis. 1995, 26: 836-844.CrossRefPubMed Wang M, Hercz G, Sherrard DJ, Maloney NA, Segre GV, Pei Y: Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis. 1995, 26: 836-844.CrossRefPubMed
29.
go back to reference Hamdy NA, Kanis JA, Beneton MN, Brown CB, Juttmann JR, Jordans JG, Josse S, Meyrier A, Lins RL, Fairey IT: Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ. 1995, 310: 358-363.CrossRefPubMedPubMedCentral Hamdy NA, Kanis JA, Beneton MN, Brown CB, Juttmann JR, Jordans JG, Josse S, Meyrier A, Lins RL, Fairey IT: Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ. 1995, 310: 358-363.CrossRefPubMedPubMedCentral
30.
go back to reference Beddhu S, Samore MH, Roberts MS, Stoddard GJ, Ramkumar N, Pappas LM, Cheung AK: Impact of timing of initiation of dialysis on mortality. J Am Soc Nephrol. 2003, 14: 2305-2312. 10.1097/01.ASN.0000080184.67406.11.CrossRefPubMed Beddhu S, Samore MH, Roberts MS, Stoddard GJ, Ramkumar N, Pappas LM, Cheung AK: Impact of timing of initiation of dialysis on mortality. J Am Soc Nephrol. 2003, 14: 2305-2312. 10.1097/01.ASN.0000080184.67406.11.CrossRefPubMed
31.
go back to reference Beddhu S, Samore MH, Roberts MS, Stoddard GJ, Pappas LM, Cheung AK: Creatinine production, nutrition, and glomerular filtration rate estimation. J Am Soc Nephrol. 2003, 14: 1000-1005. 10.1097/01.ASN.0000057856.88335.DD.CrossRefPubMed Beddhu S, Samore MH, Roberts MS, Stoddard GJ, Pappas LM, Cheung AK: Creatinine production, nutrition, and glomerular filtration rate estimation. J Am Soc Nephrol. 2003, 14: 1000-1005. 10.1097/01.ASN.0000057856.88335.DD.CrossRefPubMed
32.
go back to reference Korevaar JC, Jansen MA, Dekker FW, Jager KJ, Boeschoten EW, Krediet RT, Bossuyt PM, Netherlands Cooperative Study on the Adequacy of Dialysis Study Group: When to initiate dialysis: effect of proposed US guidelines on survival. Lancet. 2001, 358: 1046-1050. 10.1016/S0140-6736(01)06180-3.CrossRefPubMed Korevaar JC, Jansen MA, Dekker FW, Jager KJ, Boeschoten EW, Krediet RT, Bossuyt PM, Netherlands Cooperative Study on the Adequacy of Dialysis Study Group: When to initiate dialysis: effect of proposed US guidelines on survival. Lancet. 2001, 358: 1046-1050. 10.1016/S0140-6736(01)06180-3.CrossRefPubMed
33.
go back to reference Lameire N, Biesen WV, Vanholder R: Initiation of dialysis--is the problem solved by NECOSAD?. Nephrol Dial Transplant. 2002, 17: 1550-1552. 10.1093/ndt/17.9.1550.CrossRefPubMed Lameire N, Biesen WV, Vanholder R: Initiation of dialysis--is the problem solved by NECOSAD?. Nephrol Dial Transplant. 2002, 17: 1550-1552. 10.1093/ndt/17.9.1550.CrossRefPubMed
34.
go back to reference Arora P, Obrador GT, Ruthazer R, Kausz AT, Meyer KB, Jenuleson CS, Pereira BJ: Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol. 1999, 10: 1281-1286.PubMed Arora P, Obrador GT, Ruthazer R, Kausz AT, Meyer KB, Jenuleson CS, Pereira BJ: Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol. 1999, 10: 1281-1286.PubMed
35.
go back to reference Cass A, Cunningham J, Snelling P, Wang Z, Hoy W: Urban disadvantage and delayed nephrology referral in Australia. Health Place. 2003, 9: 175-182. 10.1016/S1353-8292(02)00037-0.CrossRefPubMed Cass A, Cunningham J, Snelling P, Wang Z, Hoy W: Urban disadvantage and delayed nephrology referral in Australia. Health Place. 2003, 9: 175-182. 10.1016/S1353-8292(02)00037-0.CrossRefPubMed
36.
go back to reference Mannion R, Davies HT: Reporting health care performance: learning from the past, prospects for the future. J Eval Clin Pract. 2002, 8: 215-228. 10.1046/j.1365-2753.2002.00331.x.CrossRefPubMed Mannion R, Davies HT: Reporting health care performance: learning from the past, prospects for the future. J Eval Clin Pract. 2002, 8: 215-228. 10.1046/j.1365-2753.2002.00331.x.CrossRefPubMed
37.
go back to reference Li S, McAlpine DD, Liu J, Li S, Collins AJ: Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors. Adv Ren Replace Ther. 2004, 11: 5-12. 10.1053/j.arrt.2003.10.005.CrossRefPubMed Li S, McAlpine DD, Liu J, Li S, Collins AJ: Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors. Adv Ren Replace Ther. 2004, 11: 5-12. 10.1053/j.arrt.2003.10.005.CrossRefPubMed
38.
go back to reference Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Ann Intern Med. 2004, 164: 659-663. 10.1001/archinte.164.6.659.CrossRef Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Ann Intern Med. 2004, 164: 659-663. 10.1001/archinte.164.6.659.CrossRef
Metadata
Title
Barriers to successful care for chronic kidney disease
Authors
Oliver Lenz
Durga P Mekala
Daniel V Patel
Alessia Fornoni
David Metz
David Roth
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2005
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-6-11

Other articles of this Issue 1/2005

BMC Nephrology 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine